In 2023, we generated EUR 320.4 million in revenue, and our active custom projects pipeline included 204 projects at the end of the year. The structure of revenue and the active custom projects pipeline provide insights into our activities and the innovation efforts of our customers.
Helping patients across multiple health indications
Approx. revenue split by therapeutic areas (as per 31 December 2023)
Metabolic
Oncology
Covid related
Other
Servicing a diversified customer base
Approx. revenue split by customer type (as per 31 December 2023)
Large pharma
Biotech
Other pharma & academia
Solutions for development and commercial products
Revenue by business area (as per 31 December 2023)
Custom Projects
Contract Manufacturing
Generetic & Cosmetics
“Start here – stay here”
Number of active custom projects (as per 31 December 2023)
Pre-clinical
Phase I
Phase II
Phase III